Complete Filing Data
Fresenius Medical Care AG reported Profit Loss of $1.19 billion for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Fresenius Medical Care AG did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 | FY2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | $1.19B | $740.9M | $732.5M | $894.3M | $1.22B | $1.44B | $1.44B | $2.23B | $1.55B | $1.24B | $1.03B | $1.05B | $1.11B | $1.19B | $1.07B | $978.5M | $891.1M | $817.6M | $717.1M |
| Cost of Revenue * | $12.13B | $11.41B | $10.84B | $9.87B | $9.20B | $8.42B | $8.01B | $7.42B | $6.98B | $6.36B | |||||||||
| Selling General And Administrative Expense | $3.03B | $3.14B | $3.20B | $3.17B | $2.77B | $3.13B | $3.03B | $2.89B | $3.64B | $3.13B | $2.95B | $2.64B | $2.38B | $2.22B | $2.00B | $1.82B | $1.99B | $1.88B | $1.71B |
| Research And Development Expense | $158.0M | $183.5M | $232.0M | $228.6M | $220.8M | $193.8M | $168.0M | $114.1M | $111.0M | $146.5M | $128.1M | $122.1M | $125.8M | $111.6M | $110.8M | $96.5M | $93.8M | $80.2M | $66.5M |
| Gross Profit | $5.31B | $5.08B | $5.54B | $5.40B | $5.15B | $6.02B | $5.62B | $5.18B | $5.00B | $4.74B | $4.60B | $4.15B | $3.84B | $3.83B | $3.63B | $3.36B | |||
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | $1.56B | $1.06B | $716.6M | $1.20B | $1.32B | $884.3M | $923.6M | $1.07B | $610.6M | $870.9M | |||||||||
| Share Of Profit Loss Of Associates And Joint Ventures Accounted For Using Equity Method | $181.4M | $134.9M | $121.8M | $66.6M | $92.2M | $94.5M | $73.7M | $73.3M | $67.2M | -$58.6M | $28.3M | ||||||||
| Revenue From Sale Of Goods | $4.41B | $4.25B | $4.06B | $3.98B | $3.74B | $3.74B | $3.60B | $3.28B | $3.25B | $3.06B | $3.02B | ||||||||
| Revenue From Rendering Of Services | $13.10B | $13.47B | $14.17B | $15.42B | $13.88B | $14.11B | $13.87B | $13.26B | $14.53B | $13.51B | $12.44B | ||||||||
| Profit Loss From Operating Activities | $1.83B | $1.39B | $1.37B | $1.51B | $1.85B | $2.30B | $2.27B | $3.04B | $2.36B | $2.41B | $2.13B | ||||||||
| Profit Loss Before Tax | $1.51B | $1.06B | $1.03B | $1.22B | $1.57B | $1.94B | $1.84B | $2.74B | $2.00B | $2.05B | $1.78B | ||||||||
| Profit Loss Attributable To Owners Of Parent | $978.4M | $537.9M | $499.0M | $673.4M | $969.3M | $1.16B | $1.20B | $1.98B | $1.28B | $1.14B | $954.9M | ||||||||
| Profit Loss Attributable To Noncontrolling Interests | $212.9M | $203.0M | $233.5M | $220.9M | $249.7M | $271.5M | $238.9M | $243.7M | $274.7M | $276.1M | $255.7M | ||||||||
| Other Comprehensive Income Before Tax Cash Flow Hedges | $22.4M | -$12.8M | -$4.3M | $13.6M | -$1.0M | -$188.0K | -$9.7M | $24.9M | $28.0M | $25.1M | $54.2M | ||||||||
| Other Comprehensive Income | -$1.47B | $715.9M | -$630.0M | $1.05B | $1.02B | -$1.26B | $185.5M | $323.8M | -$1.29B | $362.2M | $734.9M | ||||||||
| Income Tax Relating To Components Of Other Comprehensive Income That Will Be Reclassified To Profit Or Loss | $6.7M | -$2.6M | -$254.0K | -$4.8M | -$1.9M | $5.8M | -$2.7M | $6.7M | $8.4M | -$7.0M | $15.4M | ||||||||
| Income Tax Expense Continuing Operations | $321.0M | $316.1M | $300.6M | $325.0M | $352.8M | $500.6M | $401.6M | $511.1M | $443.1M | $625.4M | $565.0M | ||||||||
| Cost Of Sales | $14.60B | $14.58B | $14.53B | $14.50B | $12.85B | $12.32B | $12.08B | $11.39B | $11.77B | $10.95B | $10.28B | ||||||||
| Comprehensive Income Attributable To Owners Of Parent | -$356.7M | $1.18B | -$87.6M | $1.66B | $1.90B | $9.0M | $1.36B | $2.26B | $118.8M | $1.47B | $1.60B | ||||||||
| Comprehensive Income | -$275.1M | $1.46B | $102.4M | $1.94B | $2.24B | $180.8M | $1.62B | $2.55B | $269.4M | $1.78B | $1.95B | ||||||||
| Other Comprehensive Income Loss Tax | -$11.8M | -$43.4M | $68.2M | -$33.6M | $8.8M | $72.6M | $12.8M | -$19.0M | -$55.7M | -$21.9M | |||||||||
| Operating Income Loss | $2.64B | $2.33B | $2.25B | $2.26B | $2.22B | $2.07B | $1.92B | $1.76B | $1.67B | $1.58B | |||||||||
| Net Income Loss Attributable To Noncontrolling Interest | $305.6M | $283.7M | $214.5M | $145.7M | $140.2M | $106.1M | $86.9M | $74.1M | $42.4M | $38.2M | |||||||||
| Interest Expense | $452.2M | $508.0M | $495.4M | $447.5M | $470.5M | $356.4M | $305.5M | $321.4M | $361.6M | $399.6M | |||||||||
| Income Tax Expense Benefit | $683.1M | $622.1M | $583.6M | $592.0M | $605.1M | $601.1M | $578.3M | $490.4M | $475.7M | $453.8M | |||||||||
| Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments | $2.23B | $1.94B | $1.84B | $1.85B | $1.93B | $1.78B | $1.64B | $1.46B | $1.34B | $1.21B | |||||||||
| Health Care Organization Revenue | $17.91B | $16.74B | $15.83B | $14.61B | $13.80B | $12.57B | $11.84B | $11.25B | $10.61B | $9.72B | |||||||||
| Health Care Organization Patient Service Revenue | $14.95B | $13.80B | $12.55B | $11.41B | $10.77B | $9.51B | $9.07B | $8.35B | $7.74B | $7.21B | |||||||||
| Health Care Organization Other Revenue | $3.39B | $3.35B | $3.58B | $3.48B | $3.31B | $3.29B | $2.98B | $2.90B | $2.87B | $2.51B | |||||||||
| Cost Of Services | $10.66B | $9.86B | $9.13B | $8.27B | $7.65B | $6.86B | $6.57B | $5.95B | $5.55B | $5.13B | |||||||||
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | $304.1M | $278.7M | $208.5M | $143.7M | $140.0M | $104.9M | $89.4M | $75.9M | $45.1M | $47.4M | |||||||||
| Comprehensive Income Net Of Tax | $1.26B | $780.9M | $508.1M | $1.05B | $1.18B | $779.4M | $834.2M | $992.7M | $565.4M | $823.4M | |||||||||
| Comprehensive Income Attributable To Noncontrolling Interests | $81.6M | $272.2M | $190.0M | $280.2M | $339.6M | $171.8M | $259.2M | $285.7M | $150.6M | $310.6M | $344.4M | ||||||||
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net Of Tax | -$1.52B | $718.4M | -$605.8M | $799.1M | $1.03B | -$1.33B | $254.9M | $344.1M | -$1.26B | $386.5M | $713.5M | ||||||||
| Cost Of Services Rendered | $10.13B | $10.56B | $10.99B | $12.24B | $10.94B | $10.58B | $10.48B | $9.90B | $10.35B | ||||||||||
| Other Comprehensive Income Before Tax Exchange Differences On Translation | -$1.54B | $727.5M | -$607.9M | $826.8M | $1.03B | -$1.36B | $263.8M | $327.3M | -$1.28B | ||||||||||
| Income Loss From Equity Method Investments | -$64.9M | -$31.5M | -$24.8M | -$26.1M | -$17.4M | -$31.0M | -$8.9M | $4.5M | |||||||||||
| Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net Of Tax | $56.0M | -$2.5M | -$24.2M | $249.9M | -$7.5M | $78.3M | -$69.4M | -$20.4M | -$20.6M | -$24.3M | $21.3M | ||||||||
| Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Plans | $72.5M | $16.0M | -$58.5M | $318.6M | -$15.8M | $4.2M | -$99.6M | -$28.1M | $6.8M | -$31.4M | $30.2M | ||||||||
| Income Tax Relating To Components Of Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss | $23.0M | $2.9M | -$16.2M | $94.3M | $4.1M | $3.5M | -$30.2M | -$7.7M | $27.4M | $7.1M | $8.8M | ||||||||
| Other Comprehensive Income Before Tax Change In Value Of Forward Elements Of Forward Contracts | -$1.1M | $2.0M | -$1.2M | -$1.2M | -$163.0K | $3.0M | -$2.0M | -$1.3M | |||||||||||
| Cost Of Products Sold | $2.40B | $2.42B | $2.35B | $2.26B | $1.90B | $1.75B | $1.60B | $1.49B | |||||||||||
| Income Taxes Paid Refund Classified As Operating Activities | $225.8M | $444.6M | $410.1M | $334.6M | $345.1M | $301.7M | $387.7M | $358.4M | $675.2M | -$550.9M | $493.4M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 | FY2007 | FY2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $10.81B | $9.89B | $9.44B | $9.23B | $8.94B | $7.90B | $7.38B | $6.82B | $5.96B | $5.68B | $4.95B | |||||||||
| Assets | $31.00B | $33.57B | $33.93B | $35.75B | $34.37B | $31.69B | $32.93B | $26.24B | $24.03B | $25.50B | $25.37B | $25.38B | $23.12B | $22.33B | $19.53B | $17.09B | $15.82B | $14.92B | ||
| Goodwill | $13.57B | $15.17B | $14.65B | $15.79B | $14.36B | $12.96B | $14.02B | $12.21B | $12.10B | $12.96B | $13.03B | $13.08B | $11.66B | $11.42B | $9.19B | $159.9M | $7.51B | $7.31B | ||
| Equity | $10.81B | $10.50B | $10.03B | $9.23B | $9.21B | $8.06B | $7.38B | $6.82B | $5.96B | $5.68B | $4.95B | |||||||||
| Liabilities | $16.72B | $17.80B | $19.10B | $20.30B | $20.39B | $19.36B | $19.71B | $13.34B | $13.20B | $14.45B | $13.84B | $14.53B | $12.99B | $12.60B | $11.06B | $9.29B | $8.79B | $8.80B | ||
| Cash And Cash Equivalents At Carrying Value | $747.2M | $549.5M | $633.9M | $682.8M | $688.0M | $457.3M | $522.9M | $301.2M | $221.6M | $244.7M | $159.0M | |||||||||
| Cash And Cash Equivalents | $1.60B | $1.18B | $1.40B | $1.27B | $1.48B | $1.08B | $1.01B | $2.15B | $978.1M | $708.9M | $504.7M | $522.1M | ||||||||
| Investment Accounted For Using Equity Method | $663.7M | $620.8M | $642.9M | $773.7M | $786.9M | $761.1M | $696.9M | $649.8M | $647.0M | $598.2M | ||||||||||
| Cash Flows From Used In Operating Activities | $2.68B | $2.39B | $2.63B | $2.17B | $2.49B | $4.23B | $2.57B | $2.06B | $2.19B | $1.93B | $1.77B | |||||||||
| Cash Flows From Used In Investing Activities | -$722.5M | -$84.9M | -$544.2M | -$734.7M | -$1.20B | -$1.33B | -$3.29B | -$245.0M | -$991.5M | -$1.25B | -$901.9M | |||||||||
| Cash Flows From Used In Financing Activities | -$1.40B | -$2.57B | -$1.86B | -$1.62B | -$1.02B | -$2.66B | -$466.6M | -$681.7M | -$798.6M | -$519.7M | -$907.5M | |||||||||
| Adjustments For Undistributed Profits Of Investments Accounted For Using Equity Method | $181.4M | $134.9M | $121.8M | $66.6M | $92.2M | $94.5M | $73.7M | $73.3M | $57.0M | -$52.9M | $16.0M | |||||||||
| Adjustments For Increase Decrease In Trade Account Payable Related Parties | $27.2M | -$46.2M | -$10.9M | -$8.7M | $19.7M | -$16.3M | -$35.9M | $4.5M | -$110.4M | $120.7M | $24.5M | |||||||||
| Adjustments For Increase Decrease In Accounts Payable Provisions And Other Current And Non Current Liabilities | -$14.8M | $201.8M | $119.4M | -$348.1M | -$383.7M | $1.39B | -$128.9M | -$84.6M | $222.3M | $347.1M | $808.2M | |||||||||
| Adjustments For Deferred Tax Expense | -$27.2M | -$72.7M | -$122.1M | -$41.5M | $67.3M | $111.1M | $64.3M | $89.2M | -$203.0M | $232.0K | -$36.7M | |||||||||
| Adjustments For Decrease Increase In Trade Account Receivable Related Parties | $7.4M | $124.4M | -$26.3M | $30.0M | -$62.6M | $60.1M | $41.7M | -$5.8M | $32.6M | -$71.8M | -$271.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 | FY2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities | $16.7M | $14.1M | $16.1M | $36.2M | $24.4M | $15.6M | $11.5M | $54.5M | $103.2M | $16.0M | $15.7M | ||||||||
| Proceeds From Noncurrent Borrowings | $1.62B | $61.5M | $417.9M | $986.9M | $1.24B | $2.12B | $3.46B | $612.4M | $582.3M | $2.1M | $5.4M | ||||||||
| Proceeds From Contributions Of Noncontrolling Interests | $29.0M | $21.8M | $42.6M | $88.5M | $55.3M | $46.6M | $68.1M | $67.2M | $42.8M | $71.9M | $60.7M | ||||||||
| Payments For Acquisitions And Investments Net Of Cash Acquired And Purchase Of Intangible Assets | $22.0M | $23.1M | $35.2M | $59.1M | $434.2M | $259.0M | $2.22B | $445.0M | $565.7M | -$521.8M | $285.5M | ||||||||
| Increase Decrease In Cash And Cash Equivalents | $413.8M | -$241.9M | $153.4M | -$207.9M | $400.1M | $73.8M | -$1.14B | $1.17B | $269.2M | $204.2M | -$17.3M | ||||||||
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | -$141.5M | $26.2M | -$72.6M | -$23.2M | $131.2M | -$160.4M | $47.8M | $32.4M | -$132.4M | $38.0M | $25.4M | ||||||||
| Net Cash Provided By Used In Operating Activities | $2.14B | $1.96B | $1.86B | $2.03B | $2.04B | $1.45B | $1.37B | $1.34B | $1.02B | $1.20B | |||||||||
| Net Cash Provided By Used In Investing Activities | -$1.38B | -$1.00B | -$2.69B | -$1.21B | -$2.28B | -$2.35B | -$1.13B | -$698.0M | -$891.4M | -$777.0M | |||||||||
| Net Cash Provided By Used In Financing Activities | -$584.8M | -$1.01B | $805.0M | -$808.0M | $468.3M | $793.2M | -$14.7M | -$558.1M | -$156.1M | -$340.7M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 | FY2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted Earnings Loss Per Share | $3.36 | $1.83 | $1.70 | $2.30 | $3.31 | $3.96 | $3.96 | $6.45 | $4.16 | $3.73 | $3.13 | ||||||||
| Basic Earnings Loss Per Share | $3.36 | $1.83 | $1.70 | $2.30 | $3.31 | $3.96 | $3.96 | $6.47 | $4.17 | $3.74 | $3.14 | ||||||||
| Earnings Per Share Basic | $4.07 | $3.38 | $3.46 | $3.65 | $3.89 | $3.54 | $3.25 | $2.99 | $2.75 | $2.43 | |||||||||
| Earnings Per Share Diluted | $3.45 | $3.65 | $3.87 | $3.51 | $3.24 | $2.99 | $2.74 | $2.42 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 | FY2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Finance Income | $69.6M | $71.6M | $88.2M | $67.7M | $73.2M | $42.0M | $61.6M | $147.4M | $51.4M | -$63.4M | $105.1M | ||||||||
| Finance Costs | $384.4M | $407.0M | $424.6M | $360.1M | $353.6M | $410.0M | $491.1M | $448.5M | $416.2M | $426.8M | $457.9M | ||||||||
| Investment Income Interest | $46.6M | $116.6M | $84.2M | $38.9M | $44.5M | $59.8M | $25.4M | $21.4M | $24.8M | $28.6M | |||||||||
| Repayments Of Noncurrent Borrowings | $839.6M | $834.5M | $700.7M | $744.6M | $2.08B | $1.59B | $2.22B | $1.08B | $1.10B | -$662.8M | $292.8M | ||||||||
| Interest Received Classified As Operating Activities | $68.2M | $68.1M | $88.2M | $67.7M | $73.2M | $42.0M | $49.5M | $56.8M | $37.6M | $44.6M | $75.0M | ||||||||
| Interest Paid Classified As Operating Activities | $360.0M | $381.2M | $394.5M | $350.7M | $341.6M | $380.0M | $470.2M | $312.0M | $340.6M | -$354.2M | $343.6M | ||||||||
| Increase Decrease Through Changes In Ownership Interests In Subsidiaries That Do Not Result In Loss Of Control | -$360.0M | -$55.9M | -$6.0M | $491.2M | $100.5M | -$91.9M | $83.8M | $17.5M | -$17.1M | $62.9M | $20.3M | ||||||||
| Contributions From To Non Controlling Interest | -$215.4M | -$225.6M | -$246.3M | -$272.7M | -$262.8M | -$255.8M | -$220.2M | -$214.2M | -$244.4M | -$237.1M | -$224.4M | ||||||||
| Adjustments For Decrease Increase In Inventories | -$248.7M | $107.9M | -$13.1M | -$204.3M | -$48.5M | -$355.8M | -$117.5M | -$157.1M | -$62.7M | -$60.2M | -$271.3M |
Most recent annual filing with the SEC: February 24, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.